Halo Pharmaceutical, a privately held specialty pharmaceutical company, is establishing a Canadian subsidiary to be called Halo Pharmaceutical Marketing (Canada) Ltd. This company will have its headquarters in Ontario, Canada, and its main purpose will be the marketing, sale and distribution of branded pharmaceutical products currently available in other major markets but not marketed in Canada.
Halo is seeking, evaluating, and moving forward with opportunities for in-licensing and for the acquisition of branded products for both the US and Canadian markets from companies looking to rationalize their product portfolios. The Canadian subsidiary will be structured as a joint venture with CB&A Inc., a Canadian entity also based in Ontario, Canada. "We are excited about the opportunity to market a number of products in Canada as we continue to grow our North American business," commented Mohd Asif, chief financial officer of Halo Pharmaceutical.
Halo has also named Clive V Bennett as the president and CEO of this Canadian entity. Bennett, a Canadian pharmaceutical executive has over 38 years of experience in the global pharmaceutical industry. Prior to joining Halo Bennett worked for Patheon Inc for seven years. He held various top level positions at Patheon including the roles of chief scientific officer, president of Patheon USA and president of Mova Pharmaceutical, a subsidiary of Patheon. Prior to his career at Patheon Mr. Bennett was Executive VP and Head of Global Operations for Hoechst Marion Roussel headquartered in Frankfurt, Germany.
"Some of the products we are intending to launch in the Canadian market can make a valuable contribution to the country's healthcare. I am looking forward to driving that effort on behalf of Halo," said Clive Bennett.
"We are glad to have someone of Clive's stature and ability working with us and helping us to grow our North American branded pharmaceutical business," said Al Rosenston, VP of Business Development for Halo.
Halo Pharmaceutical is a specialty pharmaceutical company engaged in pharmaceutical branded product lifecycle management.